Due to health issues, this site is no longer maintained and will be shut down shortly. |
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
$235.66 -2.37 (-1.00%)
As of 03/27/2023 14:06:36 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.